Individuals involved in drug development are faced with many different challenges along the process of seeking regulatory approval. Imaging plays an important role in the assessment of the effectiveness and safety of new drugs or medical devices and, in this article, Dr. Joseph Pierro and David Raunig at ERT focus on the role of cardiac imaging in clinical trials, while acknowledging imaging’s role may also span non-clinical drug development.